Codix Bio Ltd Unveiled In Ogun

WHO and Medicines Patent Pool agree for rapid diagnostic test technology - The Canadian Media

The World Health Organization (WHO) and Medicines Patent Pool (MPP) have today announced a sublicensing agreement between MPP and a Nigerian health technology company – Codix Bio – to start development and manufacturing of rapid diagnostic tests (RDTs) using technology transferred from global in-vitro diagnostics company – SD Biosensor (SDB). This agreement will contribute to advancing equitable access to

Codix Bio Ltd Unveiled In Ogun

ShareCodix Bio Limited has officially been announced as the first African manufacturing partner selected by the World Health Organization (WHO), SD Biosensor, and the Medicines Patent Pool (MPP) under the WHO Health Technology Access Pool (HTAP) programme. This landmark designation positions Codix Bio at the forefront of rapid diagnostic test kits (RDTs) production in Africa,... The post Codix Bio Ltd Unveiled In Ogun appeared first on New Teleg…

Agreement Reached for Sublicensing Rapid Diagnostic Test Technology

GENEVA, Switzerland – The World Health Organization (WHO) and the Medicines Patent Pool (MPP) have announced a groundbreaking sublicensing agreement with Nigeria’s Codix Bio to develop and manufacture rapid diagnostic tests (RDTs). This collaboration aims to enhance equitable access to critical diagnostic tools through local production, bolstering manufacturing capabilities across Africa. The new RDT technology is designed for low- and middle-in…

Nigerian Health Tech Firm Gets License To Produce South Korean Diagnostic Innovation In WHO And MPP-Brokered Deal - Health Policy Watch

A Nigerian Health Tech firm, Codix Bio, has been awarded a license to develop and manufacture a new generation of rapid diagnostic tests (RDTs) royalty-free for African consumers, using technology transferred from a South Korean firm. The deal is a breakthrough for WHO’s new Health Technology Access Programme (HTAP) and the non-profit Medicines Patent Pool […]

WHO and Medicines Patent Pool announce sublicensing agreement for rapid diagnostic test technology - Caribbean News Global

GENEVA, Switzerland – The World Health Organization (WHO) and Medicines Patent Pool (MPP) have today announced a sublicensing agreement between MPP and a Nigerian health technology company – Codix Bio – to start development and manufacturing of rapid diagnostic tests (RDTs) using technology transferred from global in-vitro diagnostics company – SD Biosensor (SDB). This agreement will contribute to advancing equitable access to vital diagnostic t…

WHO, MPP partner with Nigerian firm for local manufacturing of rapid diagnostic tests in Africa

The World Health Organization (WHO) and the Medicines Patent Pool (MPP) have signed a sublicensing agreement with Nigerian health technology company, Codix Bio, to begin the development and local manufacturing of rapid diagnostic tests (RDTs) in Africa.  The post WHO, MPP partner with Nigerian firm for local manufacturing of rapid diagnostic tests in Africa  appeared first on Nairametrics.